BNP PARIBAS FINANCIAL MARKETS - AEGLEA BIOTHERAPEUTICS INC ownership

AEGLEA BIOTHERAPEUTICS INC's ticker is AGLE and the CUSIP is 00773J103. A total of 85 filers reported holding AEGLEA BIOTHERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
BNP PARIBAS FINANCIAL MARKETS ownership history of AEGLEA BIOTHERAPEUTICS INC
ValueSharesWeighting
Q2 2023$0
-100.0%
1
-99.7%
0.00%
Q1 2023$115
-91.4%
396
-86.7%
0.00%
Q4 2022$1,335
-99.8%
2,968
+88.4%
0.00%
Q3 2022$828,000
-68.9%
1,575
-70.1%
0.00%
Q2 2022$2,661,000
-67.7%
5,269
+47.2%
0.00%
Q1 2022$8,234,000
-84.5%
3,580
-67.9%
0.00%
Q4 2021$53,005,000
-38.0%
11,159
+3.7%
0.00%
Q3 2021$85,510,000
+161.1%
10,756
+128.6%
0.00%
Q2 2021$32,747,000
-40.6%
4,705
-32.4%
0.00%
Q1 2021$55,123,000
-20.5%
6,960
-21.0%
0.00%
Q4 2020$69,335,000
-1.7%
8,810
-11.4%
0.00%
Q3 2020$70,510,000
+294.4%
9,945
+414.5%
0.00%
Q2 2020$17,880,000
-52.5%
1,933
-76.1%
0.00%
Q1 2020$37,620,000
+52.7%
8,073
+150.4%
0.00%
Q4 2019$24,631,000
-7.2%
3,224
-6.6%
0.00%
Q3 2019$26,554,000
+77.9%
3,453
+58.5%
0.00%
Q2 2019$14,926,000
-54.0%
2,179
-46.0%
0.00%
Q1 2019$32,458,000
+536.3%
4,032
+656.5%
0.00%
Q3 2018$5,101,000
-9.5%
5330.0%0.00%
Q2 2018$5,639,0005330.00%
Other shareholders
AEGLEA BIOTHERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Yu Fan 112,044$532,0006.17%
Aisling Capital Management LP 1,691,151$8,033,0002.83%
Bain Capital Life Sciences Investors, LLC 2,847,689$13,527,0001.07%
GREAT POINT PARTNERS LLC 910,251$4,324,0000.96%
Samsara BioCapital, LLC 883,720$4,198,0000.81%
Sio Capital Management, LLC 498,500$2,368,0000.71%
UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO 245,678$1,167,0000.53%
Nantahala Capital Management 2,813,560$13,364,0000.47%
Altium Capital Management LP 293,764$1,395,0000.38%
Lion Point Capital, LP 300,000$1,425,0000.38%
View complete list of AEGLEA BIOTHERAPEUTICS INC shareholders